{"groups":[{"description":"Weekly dose of ALT-803 at assigned dose once a week for 4 weeks.","id":"FG000","title":"ALT-803, IV, 1 mcg/kg"},{"description":"Weekly dose of ALT-803 at assigned dose once a week for 4 weeks.","id":"FG001","title":"ALT-803, IV, 3 mcg/kg"},{"description":"Weekly dose of ALT-803 at assigned dose once a week for 4 weeks.","id":"FG002","title":"ALT-803, IV, 6 mcg/kg"},{"description":"Weekly dose of ALT-803 at assigned dose once a week for 4 weeks.","id":"FG003","title":"ALT-803, IV, 10 mcg/kg"},{"description":"Weekly dose of ALT-803 at assigned dose subcutaneously, once a week for 4 weeks.","id":"FG004","title":"ALT-803, SQ, 6 mcg/kg"},{"description":"Weekly dose of ALT-803 at assigned dose , subcutaneously, once a week for 4 weeks.","id":"FG005","title":"ALT-803, SQ, 10 mcg/kg"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"4"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"8"},{"groupId":"FG005","numSubjects":"9"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"4"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"8"},{"groupId":"FG005","numSubjects":"9"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}